About
Serge Saxonov co-founded 10x Genomics and has served as its Chief Executive Officer and a director since July 2012. He also served as the company's President from July 2012 until October 2012.
Before co-founding 10x Genomics, he was Vice President of Applications at QuantaLife, a privately held life sciences company that developed a droplet digital PCR platform, and earlier was Founding Architect and Director of research and development at 23andMe.
He received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics from Harvard College.
Roles
10x Genomics, Inc.
Chief Executive Officer and Director · Current role
2012–present
10x Genomics
President · Served as President in addition to CEO during the company's earliest months.
July 2012 - October 2012
QuantaLife
Vice President of Applications · Privately held life sciences company developing a droplet digital PCR platform.
May 2010 - April 2012
23andMe
Founding Architect and Director of Research and Development · Privately held personal genomics and biotechnology company.
June 2006 - May 2010
Fixed Compensation
FY 2025
Total compensation
$6,329,244
Performance Compensation
Data from FY 2025
Cash incentive
Annual cash incentive
$634,725
Stock awards
Also at 10x Genomics, Inc.